4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0001578563-22-000006
Options or other derivatives
- Chief Financial Officer acquired 450,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Sullivan Christopher Ryan · Chief Financial Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-03-08 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +400,000 | 400,000 | D |
| 2022-03-08 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +50,000 | 50,000 | D |
Loading xslF345X03/primary_doc.xml…